JP2023548368A5 - - Google Patents

Info

Publication number
JP2023548368A5
JP2023548368A5 JP2023526903A JP2023526903A JP2023548368A5 JP 2023548368 A5 JP2023548368 A5 JP 2023548368A5 JP 2023526903 A JP2023526903 A JP 2023526903A JP 2023526903 A JP2023526903 A JP 2023526903A JP 2023548368 A5 JP2023548368 A5 JP 2023548368A5
Authority
JP
Japan
Prior art keywords
formula
compound
group
alkyl
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023526903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/051310 external-priority patent/WO2022094668A1/en
Publication of JP2023548368A publication Critical patent/JP2023548368A/ja
Publication of JP2023548368A5 publication Critical patent/JP2023548368A5/ja
Pending legal-status Critical Current

Links

JP2023526903A 2020-11-06 2021-11-05 複素環式メタノン化合物及びそのアザビシクロ中間体の製造方法 Pending JP2023548368A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020904060A AU2020904060A0 (en) 2020-11-06 Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof
AU2020904060 2020-11-06
PCT/AU2021/051310 WO2022094668A1 (en) 2020-11-06 2021-11-05 Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof

Publications (2)

Publication Number Publication Date
JP2023548368A JP2023548368A (ja) 2023-11-16
JP2023548368A5 true JP2023548368A5 (https=) 2024-11-07

Family

ID=81458249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023526903A Pending JP2023548368A (ja) 2020-11-06 2021-11-05 複素環式メタノン化合物及びそのアザビシクロ中間体の製造方法

Country Status (11)

Country Link
US (1) US20230416243A1 (https=)
EP (1) EP4240740A4 (https=)
JP (1) JP2023548368A (https=)
KR (1) KR20230154789A (https=)
CN (1) CN116981461A (https=)
AU (1) AU2021374232A1 (https=)
CA (1) CA3196642A1 (https=)
CL (1) CL2023001300A1 (https=)
IL (1) IL302671A (https=)
MX (1) MX2023004940A (https=)
WO (1) WO2022094668A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026509196A (ja) * 2023-03-02 2026-03-17 アクチノゲン メディカル リミテッド アザ二環式ヘテロアリール化合物を調製するための流動化学プロセス
WO2025073002A1 (en) * 2023-10-03 2025-04-10 Actinogen Medical Limited Tablet formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410961B2 (en) * 2004-01-20 2008-08-12 Merck & Co., Inc. 2,6-disubstituted piperiddines as modulators
MY145633A (en) * 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ES2366058T3 (es) * 2006-03-01 2011-10-14 Theravance, Inc. Compuestos de 8-azabiciclo[3.2.1]octano como antagonistas de los receptores opioides mu.
AR073920A1 (es) * 2008-10-23 2010-12-09 Boehringer Ingelheim Int Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion.
US8642621B2 (en) * 2009-09-16 2014-02-04 The University Of Edinburgh (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use
KR101445012B1 (ko) * 2009-12-17 2014-09-26 머크 샤프 앤드 돔 코포레이션 Ｓｙｋ 억제제로서의 아미노피리미딘
EP2525659B1 (en) * 2010-01-19 2019-02-27 Merck Sharp & Dohme Corp. PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
AU2011247116B2 (en) * 2010-04-29 2015-12-03 The University Of Edinburgh 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1H - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -HSD1

Similar Documents

Publication Publication Date Title
ES2619374T3 (es) Procedimiento de preparación de sal derivada de diamina ópticamente activa
CN102985416B (zh) 制备凝血酶特异性抑制剂的方法
CN101765595A (zh) 制备伏立康唑的方法
IL278533B1 (en) Process for the preparation of 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
JP2023548368A5 (https=)
RU2742005C2 (ru) Способы получения 4-алкокси-3-(ацил или алкил)оксипиколинамидов
WO2014192030A2 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
JP2018507858A (ja) トピロキソスタット及びその中間体の調製のための方法
KR20180038460A (ko) 세포독성 벤조다이아제핀 유도체의 제조 방법
US10464898B2 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
CN117813304A (zh) 用于制备阿夫凯泰的方法
KR20150027986A (ko) 고순도 페메트렉세드 제조를 위한 향상된 중간체 제조 방법 및 이를 사용하여 고순도 페메트렉세드를 제조하는 방법
CA2975072A1 (en) Method for producing pyrazinecarboxamide compound and synthetic intermediate thereof
CA2761399C (en) Process for the production of bendamustine alkyl ester, bendamustine, and derivatives thereof
JP2023524692A5 (https=)
JP5787893B2 (ja) ビフェニルイミダゾール化合物の調製方法
KR101427221B1 (ko) 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
TWI887245B (zh) 用於產生二氮雜螺內醯胺化合物之方法及中間物
AU2007213270A1 (en) Improved process for producing nitroisourea derivatives
RU2512591C2 (ru) Способ получения плевромутилинов
KR20150066777A (ko) 광학활성 인돌린 유도체 및 이의 제조방법
KR20010092130A (ko) 신규한 티아졸 화합물을 이용한 세팔로스포린계항생물질의 제조 방법
EP2627654A1 (en) Method of making azaindazole derivatives
IL311879A (en) Method for producing compound or pharmaceutically acceptable salt thereof
CN101245078A (zh) 头孢噻呋的双苄基乙二胺盐及其制备方法和应用